B12 and Folate Deficiencies As Outcome Variables Following Allogeneic Transplant

Key Points

• B12 and folate deficiencies significantly impact hematopoiesis after allogeneic transplant, affecting recovery outcomes.
• The study observed deficiencies in 45% of recipients within six months after the transplant.
• Assessment using clinical evaluations shows that addressing these deficiencies can improve patient outcomes significantly.
• Further investigation is needed to establish routine screening protocols for these nutrient deficiencies after transplantation.